Increased Gardnerella vaginalis urogenital biofilm in inflammatory bowel disease

Journal of Crohn's and Colitis

Volumn 8, Issue 6, 2014, Pages 543-549

  Schilling, Johannes ^a   Loening Baucke, Vera ^a   Dörffel, Yvonne ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Crohn's disease; FISH; Gardnerella vaginalis; Ulcerative colitis; Urogenital biofilm

Indexed keywords

CORTICOSTEROID; STEROID;

ADULT; AGED; ANUS FISTULA; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; BIOFILM; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GARDNERELLA VAGINALIS; HUMAN; HUMAN CELL; INFLAMMATORY BOWEL DISEASE; INTESTINE EPITHELIUM CELL; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PRIORITY JOURNAL; ULCERATIVE COLITIS; URINALYSIS; VAGINA FLORA; CASE CONTROL STUDY; COMPLICATION; FEMALE UROGENITAL DISEASES; GRAM-POSITIVE BACTERIAL INFECTIONS; MALE UROGENITAL DISEASES; MICROBIOLOGY; MIDDLE AGED; VAGINOSIS, BACTERIAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOFILMS; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FEMALE UROGENITAL DISEASES; GARDNERELLA VAGINALIS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFLAMMATORY BOWEL DISEASES; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; VAGINOSIS, BACTERIAL; YOUNG ADULT;

EID: 84899905793     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.11.015     Document Type: Article

References (34)

1. Swidsinski A., Loening-Baucke V., Vaneechoutte M., Doerffel Y. Active Crohn's disease and ulcerative colitis can be specifically diagnosed and monitored based on the biostructure of the fecal flora. Inflamm Bowel Dis 2008, 14:147-161.
2. Swidsinski A., Ladhoff A., Pernthaler A., Swidsinski S., Loening-Baucke V., Ortner M., et al. Mucosal flora in inflammatory bowel disease. Gastroenterology 2002, 122:44-54.
3. Sokol H., Pigneur B., Watterlot L., Lakhdari O., Bermúdez-Humarán L.G., Gratadoux J.J., et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients. Proc Natl Acad Sci U S A 2008, 105:16731-16736.
4. Sokol H., Seksik P., Rigottier-Gois L., Lay C., Lepage P., Podglajen I., et al. Specificities of the fecal microbiota in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:106-111.
5. Williams H.R., Cox I.J., Walker D.G., North B.V., Patel V.M., Marshall S.E., et al. Characterization of inflammatory bowel disease with urinary metabolic profiling. Am J Gastroenterol 2009, 104:1435-1444.
6. Swidsinski A., Doerffel Y., Loening-Baucke V., Swidsinski S., Verstraelen H., Vaneechoutte M., et al. Gardnerella biofilm involves females and males and is transmitted sexually. Gynecol Obstet Invest 2010, 70:256-263.
7. Dong Q., Nelson D.E., Toh E., Diao L., Gao X., Fortenberry J.D., et al. The microbial communities in male first catch urine are highly similar to those in paired urethral swab specimens. PLoS One 2011, 6(5):e19709. 10.1371/journal.pone.0019709.
8. Swidsinski A., Mendling W., Loening-Baucke V., Ladhoff A., Swidsinski S., Hale L.P., et al. Adherent biofilms in bacterial vaginosis. Obstet Gynecol 2005, 106:1013-1023.
9. Swidsinski A., Verstraelen H., Loening-Baucke V., Swidsinski S., Mendling W., Halwani Z. Presence of a polymicrobial endometrial biofilm in patients with bacterial vaginosis. PLoS One 2013, 8(1):e53997. 10.1371/journal.pone.0053997.
10. Best W.R., Becktel J.M., Singleton J.W., Kern F. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976, 70:439-444.
11. Lichtiger S., Present D.H., Kornbluth A., Gelernt I., Bauer J., Galler G., et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994, 330:1841-1845.
12. Van Assche G., Dignass A., Panes J., Beaugerie L., Karagiannis J., Allez M., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis 2010, 4:7-27.
13. Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis 2008, 2:1-23.
14. Amann R.I., Binder B.J., Olson R.J., Chisholm S.W., Devereux R., Stahl D.A. Combination of 16S rRNA-targeted oligonucleotide probes with flow cytometry for analyzing mixed microbial populations. Appl Environ Microbiol 1990, 56:1919-1925.
15. Harmsen H.J., Wildeboer-Veloo A.C., Grijpstra J., Knol J., Degener J.E., Welling G.W. Development of 16S rRNA-based probes for the Coriobacterium group and the Atopobium cluster and their application for enumeration of Coriobacteriaceae in human feces from volunteers of different age groups. Appl Environ Microbiol 2000, 66:4523-4527.
16. Langendijk P.S., Schut F., Jansen G.J., Raangs G.C., Kamphuis G.R., Wilkinson M.H., et al. Quantitative fluorescence in situ hybridization of Bifidobacterium spp. with genus-specific 16S rRNA-targeted probes and its application in fecal samples. Appl Environ Microbiol 1995, 61:3069-3075.
17. Bohnert J., Hübner B., Botzenhart K. Rapid identification of Enterobacteriaceae using a novel 23S rRNA-targeted oligonucleotide probe. Int J Hyg Environ Health 2000, 203:77-82.
18. Harmsen H.J., Elfferich P., Schut F., Welling G.W. A 16S rRNA-targeted probe for detection of Lactobacilli and Enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 1999, 1:3-12.
19. Manz W., Amann R., Ludwig W., Vancanneyt M., Schleifer K.H. Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga-flavobacter-bacteroides in the natural environment. Microbiology 1996, 142:1097-1106.
20. Franks A.H., Harmsen H.J., Raangs G.C., Hansen G.J., Schut F., Welling G.W. Variations of bacterial populations in human feces measured by fluorescence hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998, 64:3336-3345.
21. Swidsinski A. Standards for bacterial identification by fluorescence In situ hybridization within eukaryotic tissue using ribosomal rRNA-based probes. Inflamm Bowel Dis 2006, 12:824-826. [author reply 826-7].
22. Sobel J.D. Bacterial vaginosis. Annu Rev Med 2000, 51:349-356.
23. Carey J.C., Klebanoff M.A., Hauth J.C., Hillier S.L., Thom E.A., Ernest J.M., et al. Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 2000, 342:534-540.
24. Gravett M.G., Hitti J., Hess D.L., Eschenbach D.A. Intrauterine infection and preterm delivery: evidence for activation of the fetal hypothalamic-pituitary-adrenal axis. Am J Obstet Gynecol 2000, 182:1404-1413.
25. Goldenberg R.L., Hauth J.C., Andrews W.W. Intrauterine infection and preterm delivery. N Engl J Med 2000, 342:1500-1507.
26. Guaschino S., De Seta F., Piccoli M., Maso G., Alberico S. Aetiology of preterm labour: bacterial vaginosis. Br J Obstet Gynaecol 2006, 113:46-51.
27. Leitich H., Bodner-Adler B., Brunbauer M., Kaider A., Egarter C., Husslein P. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis. Am J Obstet Gynecol 2003, 189:139-147.
28. Kornfeld D., Cnattingius S., Ekbom A. Pregnancy outcomes in women with inflammatory bowel disease - a population-based cohort study. Am J Obstet Gynecol 1997, 177:942-946.
29. Dominitz J.A., Young J.C., Boyko E.J. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002, 97:641-648.
30. Mahadevan U., Sandborn W.J., Li D.K., Hakimian S., Kane S., Corley D.A. Pregnancy outcome in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007, 133:1106-1112.
31. Shim L., Eslick G.D., Simring A.A., Murray H., Weltman M.D. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD). J Crohns Colitis 2011, 5:234-238.
32. Schnitzler F., Fidder H., Ferrante M., Ballet V., Noman M., Van Assche G., et al. Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy. Inflamm Bowel Dis 2011, 17:1846-1854.
33. Rahimi R., Nikfar S., Rezaie A., Abdollahi M. Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis. Reprod Toxicol 2008, 25:271-275.
34. Molnár T., Farkas K., Nagy F., Lakatos P.L., Miheller P., Nyári T., et al. Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: a case-control study. Scand J Gastroenterol 2010, 45:1302-1306.